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In our previous papers, [11] [12] [13] we reported analyses of the constituents of some crude drugs using capillary electrophoresis (CE). To aid in the evaluation of crude drugs, we succeeded in our attempt to separate and determine the quantity of swertiamarin in Swertia herb. Subsequently, we applied the same analytical condition to estimate the swertiamarin contents in Japanese pharmacopoeia stomachic preparations, in OTC gastroenteric drugs and in OTC hair tonics containing Swertia herb.
Experimental

Materials
Swertia herbs were obtained from markets in Kobe, Osaka, Sendai and Tokyo. Pharmacopoeia preparations containing Swertia herb were made in our laboratory. OTC drugs and hair tonics containing Swertia herb were purchased from a pharmacy in Sendai. Authentic swertiamarin and arbutin were obtained from Nacalai Tesque (Kyoto, Japan). Sodium tetraborate and sodium hydroxide were also purchased from Nacalai Tesque.
Capillary electrophoresis
A Quanta 4000 system (Waters Associates) with an 805 Data station (Waters Associates) was used as the electrophoretic apparatus. An AccuSep capillary (75 µm i.d. × 60 cm, Waters Associates) and a UV detector within the apparatus (on-column detection at 254 nm) were employed as the capillary column and detector, respectively. Injection of the sample solution was performed by a hydrostatic method (10 s). A 50 mM sodium tetraborate-100 mM sodium hydroxide solution (3:2, pH 10.0) was used as the electrophoretic buffer. The applied voltage during CE was 10 kV. The swertiamarin content was estimated based on the peak area using arbutin as an internal standard.
Preparation of samples
Swertiamarin was extracted from Swertia herb using a procedure described in the literature 6 and briefly outlined below. Ten milligrams of a well-dried powder of the crude drug were accurately weighed and extracted with 40 ml of the water by shaking for 15 min; then the mixture was filtered and the filtrate was put into a 50 ml measuring flask. Aqueous solution of the internal standard was added, followed by adjustment to 50 ml with water. After filtration through a membrane filter (50 µm), the filtrate was provided for CE analysis. Swertiamarin in Swertia and sodium bicarbonate powder (SSP) and gastroenteric drugs (A -E) were also extracted with water (A, B, E, 80 ml/10 mg of Swertia herb contained in each drug; SSP, 40 ml/10 mg; C, D, 40 ml/5 mg) by shaking for 15 min, followed by centrifugal filtration and adjustment to 100 ml (in the case of SSP, C, D, to 50 ml) in a measuring flask as described above. These samples were used for CE analyses after membrane filter filtration. Bitter tincture and two hair tonics (F, G) were directly filtered through a membrane filter and each swertiamarin content was estimated by CE. The hair tonic (H, 2 g) was extracted with 80 ml of the water and the mixture was filtered. The filtrate was adjusted to 100 ml with water in the measuring flask and subjected to CE analysis in a similar fashion. Formulas for the preparations analyzed here are listed in Table 1 .
Results and Discussion
With reference to the previously reported 14 separation condition of iridoid glycosides in CE, several electrophoretic buffers in the vicinity of pH 9 and 10 were examined and 50 mM sodium tetraborate-100 mM sodium hydroxide buffer solution (pH 10) was employed for electrophoresis. When CE was performed at 10 kV, the migration current was about 55 µA, while the migration time was around 14 min, both of which were suitable. The detection limit was about 0.5 µg/ml and arbutin could be used as an internal standard. According to the literature, 6 Swertia herb was treated with water, showing excellent extraction efficiency, to extract the swertiamarin. The electropherogram of the water extract of Swertia herb is shown in Fig. 1 . The analysis can be finished within 20 min under this condition.
The quantities of swertiamarin in the Swertia herb samples are shown in Table 2 .
The swertiamarin contents in the commercially procured Swertia herbs remained constant at about 6%. These seemed to be cultivated plants, while the wild Swertia herb demonstrated higher swertiamarin content (more than 8%). These results almost agree with those from HPLC analyses previously reported. 10 The possibility of applying this analytical condition to an estimation of the swertiamarin content in various drugs containing Swertia herb was then examined. SSP, one of the stomachic preparations in the Pharmacopoeia, had no problem in determination, but for bitter tincture, another stomachic preparation in the Pharmacopoeia, it was impossible to determine the swertiamarin content due to interfering peaks 886 ANALYTICAL SCIENCES JULY 2001, VOL. 17 Table 1 Each value represents the mean ± S.E., n = 3.
arising from other crude drugs, especially bitter orange peel, in the mixture. The electropherograms of SSP and bitter tincture are exhibited in Figs. 2 and 3 , respectively. Next, 5 OTC gastroenteric drugs on the market (A -E) were inspected. It was found that in 4 drugs, labeled A -D, it was possible to determine the swertiamarin content. However, arbutin could not be used as the internal standard for drugs C and D due to interfering peaks. Accordingly, an absolute calibration method was utilized for the determination. The electropherograms of these drugs are shown in Fig. 4 . Drug E, which was impossible to estimate, contained many kinds of crude drugs and the interfering peaks seemed to be derived from Magnolia bark.
Further, 3 hair tonics on the market (F -H) were checked to show that the swertiamarin contents in drugs F and H could be estimated under the same CE condition. The electropherograms of these drugs are also shown in Fig. 4 . The results of swertiamarin estimation of 10 preparations containing the Swertia herb as described above are summarized in Table 3 . Except for that in hair tonics, the blended amount of Swertia herb in each drug is known. Therefore, the rate of swertiamarin 887 ANALYTICAL SCIENCES JULY 2001, VOL. 17 Fig. 4 Capillary electropherograms of water extracts of various preparations. The CE conditions and peak identities are the same as in Fig. 1 . A -E, gastroenteric drugs; F -H, hair tonics. ↓, interfering peak. content in each Swertia herb blended in each drug could be calculated. The swertiamarin content revealed a limited variation ranging from 4.81% to 6.39%. This result is convincing.
As there are some advantages to CE, such as higher number of theoretical plates, different separation mode from HPLC, and shorter preconditioning time due to purging and recharging the capillary column after elution of necessary compounds, CE is considered appropriate for evaluating and controlling the quality of crude drugs and prescriptions containing crude drugs. As described above, swertiamarin in Swertia herb could be determined rapidly and simply after a brief pretreatment. However, the swertiamarin content of a few drugs containing Swertia herb could not be estimated under the same analytical condition.
Therefore, reexamination of electrophoretic condition or adoption of another mode, such as micellar electrokinetic chromatography, should be considered. In addition, the internal standard, which will result in a more exact estimation, could be used in CE analysis of most drugs examined. Application of CE seems to be useful for analysis of swertiamarin in Swertia herb and its blended preparations as another analytical method. 
